Q+A: Why a Singapore investor is betting on Brisbane’s biotech future
Published June 11, 2026
Brisbane is rapidly emerging as one of Australia's most important healthcare and life sciences hubs, and global investors are taking notice.
Sean Aylmer speaks with John Ratcliffe, CEO of Altea Investments, about the company's decision to launch a new life sciences incubator at QIMR Berghofer Medical Research Institute. They also discuss how AI is accelerating scientific research, and why global capital increasingly follows talent rather than geography.
Fear & Greed is working with the Brisbane Economic Development Agency to explore why international businesses are choosing Brisbane.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.